Effect of Liraglutide on Fatty Liver Content Evaluated by Proton-spectroscopy (1H-spectroscopy) and Lipoprotein Kinetic, in Patients With Type 2 Diabetes

Trial Profile

Effect of Liraglutide on Fatty Liver Content Evaluated by Proton-spectroscopy (1H-spectroscopy) and Lipoprotein Kinetic, in Patients With Type 2 Diabetes

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Feb 2018

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Dyslipidaemias; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms LIRA-NAFLD/LIP
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 12 Oct 2016 Results (n=80) assessing effect of liraglutide therapy on liver fat content published in the Journal of Clinical Endocrinology and Metabolism
    • 16 Sep 2016 Results of invivo kinetic study presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top